(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one

C20H16F3N3O2S — CID 95057486

IUPAC(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one
SMILESO=C(/C=C/c1cccs1)N1CCC[C@H]1c1nc(-c2cccc(C(F)(F)F)c2)no1
InChIInChI=1S/C20H16F3N3O2S/c21-20(22,23)14-5-1-4-13(12-14)18-24-19(28-25-18)16-7-2-10-26(16)17(27)9-8-15-6-3-11-29-15/h1,3-6,8-9,11-12,16H,2,7,10H2/b9-8+/t16-/m0/s1
InChIKeyPHJKIFYDWOWQAK-FDMDGMSGSA-N
MW419.43 g/mol
LogP5.19
Rot. Bonds4

About (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one

(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one (PubChem CID 95057486) has the molecular formula C20H16F3N3O2S and a molecular weight of 419.43 g/mol. Its IUPAC name is (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one.

Molecular Properties

Compound Name(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one
PubChem CID95057486
Molecular FormulaC20H16F3N3O2S
Molecular Weight419.43 g/mol
Exact Mass419.09
IUPAC Name(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one
SMILESO=C(/C=C/c1cccs1)N1CCC[C@H]1c1nc(-c2cccc(C(F)(F)F)c2)no1
InChIInChI=1S/C20H16F3N3O2S/c21-20(22,23)14-5-1-4-13(12-14)18-24-19(28-25-18)16-7-2-10-26(16)17(27)9-8-15-6-3-11-29-15/h1,3-6,8-9,11-12,16H,2,7,10H2/b9-8+/t16-/m0/s1
InChIKeyPHJKIFYDWOWQAK-FDMDGMSGSA-N
XLogP5.19
TPSA59.23 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500419.43
LogP ≤ 55.19
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one?
The IUPAC name of (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one (CID 95057486) is (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one.
What is the SMILES notation for (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one?
The canonical SMILES for (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one is O=C(/C=C/c1cccs1)N1CCC[C@H]1c1nc(-c2cccc(C(F)(F)F)c2)no1.
What is the InChIKey of (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one?
The InChIKey is PHJKIFYDWOWQAK-FDMDGMSGSA-N. The full InChI is InChI=1S/C20H16F3N3O2S/c21-20(22,23)14-5-1-4-13(12-14)18-24-19(28-25-18)16-7-2-10-26(16)17(27)9-8-15-6-3-11-29-15/h1,3-6,8-9,11-12,16H,2,7,10H2/b9-8+/t16-/m0/s1.
What are the key properties of (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one?
(E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one has a molecular weight of 419.43 g/mol, XLogP of 5.19, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-thiophen-2-yl-1-[(2S)-2-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]prop-2-en-1-one is sourced from PubChem (CID 95057486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).